PN400 (VIMOVO)

DRUG4 trials

Sponsors

POZEN

Conditions

Gastric Ulcer

Phase 3

A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)

CompletedNCT00527904

POZENGastric Ulcer

Start: 2007-03-31End: 2009-03-31Updated: 2010-08-31

Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen

CompletedNCT00527787

POZENGastric Ulcer

Start: 2007-09-30End: 2008-10-31Updated: 2010-12-28

Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec

TerminatedNCT00594854

POZENGastric Ulcer

Start: 2007-09-30End: 2008-09-30Updated: 2010-09-22

Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen

CompletedNCT01129011

POZENGastric Ulcer

Start: 2007-09-30End: 2008-10-31Updated: 2010-12-28

Related Papers

Long-term safety of naproxen and esomeprazole magnesium fixed-dose combination: phase III study in patients at risk for NSAID-associated gastric ulcers.

2011-02-1413 citations